Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: Results from a multicenter EUSTAR study of European Caucasian patients

Annals of the Rheumatic Diseases

Volumn 66, Issue 2, 2007, Pages 257-259

  Allanore, Y ^a,b   Borderie, D ^b   Airo, P ^c   Guiducci, S ^d   Czirjak L ^e   Nasonov, E L ^f   Riemekasten, G ^g   Caramaschi, P ^h   Majdan, M ⁱ   Krasowska, D ⁱ   Friedl, E ^j   Lemarechal, H ^b   Ananieva, L P ^f   Nievskaya, T ^f   Ekindjian, O G ^b   Matucci Cerinic, M ^d   Kahan, A ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Department of Rheumatology and Immunology ^*  (France)

^c University of Florence ^*  (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF PÉCS   (Hungary)

^f V A NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY   (Russian Federation)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h UNIVERSITY HOSPITAL OF VERONA   (Italy)

ⁱ MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^j MEDICAL UNIVERSITY OF GRAZ   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; VASCULOTROPIN;

ADULT; AGED; ALLELE; ANGIOGENESIS; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION MAPPING; SYSTEMIC SCLEROSIS;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SCLERODERMA, SYSTEMIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846890470     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.054346     Document Type: Article

References (15)

1. Kahaleh BM. Vascular involvement in systemic sclerosis. Clin Exp Rheumatol 2004;22(Suppl 33):s19-23.
2. Cutolo M, Grassi W, Matucci Cerinic M. Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum 2003;48:3023-30.
3. Allanore Y, Borderie D, Lemaréchal H, Ekindjian OG, Kahan A. Nifedipine decreases s-VCAM-1 concentrations and oxidative stress in systemic sclerosis, but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1. Arthritis Res Ther 2004;6:R309-14.
4. Distler O, del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor (VEGF) are a feature of earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res Ther 2002;4:r11.
5. Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J, et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 2004;95:109-16.
6. Marumo T, Schini-Kerth VB, Busse R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 1999;48:1131-7.
7. Rogers MS, D'Amato RJ. The effect of genetic diversity on angiogenesis. Exp Cell Res 2005;312:561-74.
8. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000;12:1232-5.
9. Rueda B, Lopez-Nevot MA, Lopez-Diaz MJ, Garcia-Porrua C, Martin J, Gonzalez-Gay MA. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. J Rheumatol 2005;32:1737-41.
10. Rueda B, Perez-Armengol C, Lopez-Lopez S, Garcia-Porrua C, Martin J, Gonzalez-Gay MA. Association between functional haplotypes of vascular endothelial growth factor and renal complications in henoch-schlein purpura. J Rheumatol 2006;33:69-73.
11. Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999;60:1245- 9.
12. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000;37:443-8.
13. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Kreig T, Medsger Jr TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis[editorial]. J Rheumatol 1988;15:202-5.
14. Matucci Cerinic M, D'Angelo S, Denton C, Vlachoyannopoulos P, Silver R. Assessment of lung involvement. Clin Exp Rheumatol 2003;21(Suppl 29):s19.
15. Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J Diabetes Complications 2003;17:1-6.